ライフサイエンスコーパス: per

1 hemoglobin less than 6.5% (odds ratio = 1.08 per 0.1 stress hyperglycemia ratio increment; p < 0.001)

2 ual to 6.5% (48 mmol/mol) (odds ratio = 1.08 per 0.1 stress hyperglycemia ratio increment; p = 0.005)

3 f 2.80 milliseconds (95% CI: -3.17 to -2.42) per 1 degrees C increase.

4 rome, stroke, or coronary revascularisation) per 1 mmol/L reduction in LDL cholesterol.

5 c acid (2.9 wk; 95% CI: 1.0, 4.9; P = 0.004) per 1% of energy intake.

6 s 17.2 per 1,000 patient days before and 7.6 per 1,000 patient days after the initiative (56% decreas

7 Mean monthly cardiac arrest rate was 17.2 per 1,000 patient days before and 7.6 per 1,000 patient

8 use was tracked using days of therapy (DOT) per 1,000 patient-days, and data were analyzed by an int

9 14.1] and 871.1 [95% CI: 852.3, 890.6] cases per 1,000 person-years, respectively) and peaked in July

10 articipants died, corresponding to 22 deaths per 1,000 person-years.

11 sociodemographic subgroups (e.g., CVD rates per 1,000 person-years: age 18 to 24 years, 0.64; age 25

12 The risk of death decreased by 17% per 1,000-MBq increase in the total applied activity.

13 seasonal ice duration of 6.10 +/- 0.08 days per 1- degrees C increase in global mean surface air tem

14 iability in eyes with severe glaucoma (-1.25 per 1-point decrease in SS; P < 0.05) compared with eyes

15 th mild or moderate glaucoma (-0.67 to -0.75 per 1-point decrease in SS; P < 0.05).

16 al confounders, the RRs (95% CIs) of frailty per 1-SD increase in the AMED, DASH, and AHEI-2010 score

17 The odds ratios (ORs) per 1-SD increase of log-transformed alcoholic drinks pe

18 5-year progression ranged from 1.18 to 1.51 (per 1-standard deviation increment in relative abundance

19 nt CKD (stage 3 or higher) as eGFR<60 ml/min per 1.73 m(2) and >=25% decline from baseline, CKD-relat

20 association between baseline eGFR <60 ml/min per 1.73 m(2) and risk for dementia or MCI.

21 rular filtration rate >=25 to <75 mL per min per 1.73 m(2), treated with optimized renin-angiotensin

22 ated that increased inferior RNFL thickness (per 10 mum) was associated with higher odds of long-term

23 0.001), and greater superior RNFL thickness (per 10 mum) was associated with higher odds of visual ac

24 r MRSA infection (from 114.18 to 93.68 cases per 10,000 hospitalizations), VRE infection (from 24.15

25 obacter species infection (from 3.33 to 2.47 per 10,000), and MDR P. aeruginosa infection (from 13.10

26 zations), VRE infection (from 24.15 to 15.76 per 10,000), carbapenem-resistant acinetobacter species

27 P. aeruginosa infection (from 13.10 to 9.43 per 10,000), with decreases ranging from -20.5% to -39.2

28 (odds ratio [OR] = 1.12 [95% CI = 1.01-1.25] per 10-mug/m(3) increase in NO(2) exposure).

29 000 for ipilimumab plus nivolumab, and 3740 per 100 000 among all ICIs.

30 mmon ophthalmic immune-related AE, were 8209 per 100 000 for ipilimumab (anti-CTLA-4), 2542 per 100 0

31 100 000 for pembrolizumab (anti-PD-1), 5556 per 100 000 for ipilimumab plus nivolumab, and 3740 per

32 r 100 000 for ipilimumab (anti-CTLA-4), 2542 per 100 000 for nivolumab (anti-PD-1), 2451 per 100 000

33 per 100 000 for nivolumab (anti-PD-1), 2451 per 100 000 for pembrolizumab (anti-PD-1), 5556 per 100

34 confidence interval [CI], 1754-1789) and 303 per 100 000 person-years (95% CI, 295-310), respectively

35 sepsis and severe sepsis in adults was 1772 per 100 000 person-years (95% confidence interval [CI],

36 00 000 persons for osteomyelitis, 0.5 to 0.9 per 100 000 persons for central nervous system abscesses

37 izations with SUDs increased from 1.1 to 2.1 per 100 000 persons for IE, 1.4 to 2.4 per 100 000 perso

38 o 2.1 per 100 000 persons for IE, 1.4 to 2.4 per 100 000 persons for osteomyelitis, 0.5 to 0.9 per 10

39 l nervous system abscesses, and 24.4 to 32.9 per 100 000 persons for skin and soft tissue infections.

40 ical cancer incidence of four or fewer cases per 100 000 women-years and ten or fewer cases per 100 0

41 r 100 000 women-years and ten or fewer cases per 100 000 women-years, and an 85% or greater reduction

42 iated with 3.52 fewer expected kidney donors per 100 eligible deaths than non-Gulf States.

43 ic content of 0.72 g gallic acid equivalents per 100 g of soybean hull was obtained with an antioxida

44 h represented incidences of 63.3 versus 69.4 per 100 patient years, respectively); rates of hospitali

45 rrent stroke or TIA: 2.32 versus 0.75 events per 100 patient-years (hazard ratio [HR], 3.05 [95% CI,

46 he rate of deaths from cardiovascular causes per 100 patient-years was 2.2 with sotagliflozin and 2.4

47 icularly in months 0-3 post-transplant (1.18 per 100 patient-years).

48 5 participants who had initiated ART was 1.9 per 100 person-years (95% CI 0.9-3.9).

49 The rate of the primary outcome (per 100 person-years) increased with HF duration: 10.2 (

50 ugs (PWID), with a mean incidence of 0.9-1.4 per 100 person-years.

51 placebo group (incidence, 2.5 vs. 3.6 events per 100 person-years; hazard ratio, 0.69; 95% confidence

52 icantly greater in LMICs in South Asia (3.06 per 100 women) and Sub-Saharan Africa (2.76 per 100 wome

53 per 100 women) and Sub-Saharan Africa (2.76 per 100 women), compared with high-income countries like

54 ncome countries like the United States (1.69 per 100 women).

55 dditional 91.1 (54.3, 127.3) gonorrhea cases per 100,000 MSM population each year without increasing

56 The number of excess deaths, excess deaths per 100,000 people and relative increase in deaths were

57 iscleritis and scleritis were 15.39 and 5.54 per 100,000 per year, respectively.

58 her in women and men with OSA (17.2 and 40.8 per 100,000).

59 m the late 2000s through early 2010s (images per 1000 enrollees per year for Medicare: -301 [95% CI:

60 growth through the mid to late 2000s (images per 1000 enrollees per year for Medicare: 91 [95% confid

61 ed with a woman's first DBT examination (6.1 per 1000 examinations vs 4.4-5.7 per 1000 examinations w

62 nation (6.1 per 1000 examinations vs 4.4-5.7 per 1000 examinations with at least one prior DBT examin

63 The overall incidence of BIA-ALCL was 1.79 per 1000 patients (1 in 559) with textured implants and

64 e epidemic control (incidence of 1 infection per 1000 person-years) by 2030.

65 across all sites (incidence rate 24.9 cases per 1000 person-years).

66 stoperative AF (incidence rate, 42.5 vs 25.0 per 1000 person-years; absolute RD at 5 years, 6.2%; 95%

67 s (1 in 559) with textured implants and 1.15 per 1000 textured implants (1 in 871), with a median tim

68 reening was -1.0 (95% CI, -2.3 to 0.1) death per 1000 women (hazard ratio, 0.78 [CI, 0.63 to 0.95]) (

69 (RR) percentage, cancer detection rate (CDR) per 1000 women screened, false-negative rate per 1000 wo

70 per 1000 women screened, false-negative rate per 1000 women screened, positive predictive value of re

71 0 women screened; 33 of 56 839) than DM (0.9 per 1000 women screened; 0.4, 1.6 per 1000 women screene

72 .6 per 1000 women screened; 95% CI: 0.4, 0.8 per 1000 women screened; 33 of 56 839) than DM (0.9 per

73 ative rates were slightly lower for DBT (0.6 per 1000 women screened; 95% CI: 0.4, 0.8 per 1000 women

74 an DM (0.9 per 1000 women screened; 0.4, 1.6 per 1000 women screened; nine of 10 511) overall (P = .3

75 h an incremental prevalence increase of 8.2% per 250 exposure hours (P < .0001).

76 Hazard ratios per 5 BMI units, calculated using proportional hazards r

77 ays and 2 years (adjusted hazard ratio: 0.91 per -5 mm Hg PASP; 95% confidence interval: 0.86 to 0.96

78 0 samples), it is optimal to draw one sample per alternative, favoring breadth.

79 Per- and polyfluoroalkyl substances (PFASs) are widespre

80 uorescence protein-treated controls (1012 vg per animal, n = 10 per group) with PHP.B vectors.

81 n determined as 1500 (+/-8%) water molecules per Ar(1800)(+) ion, consistent with our results from mo

82 etate signal), linearity (range 0.05-5.00 mg per assay), sensitivity (limit of detection and quantifi

83 (ACR20) response at week 24 in all patients per assigned treatment group.

84 by delivering long reads (>10 kbp) with high per-base accuracy (>99.9%).

85 There was a quadratic fit between time per bite and bite mass (P = 0.006).

86 uld increase by a factor of 1.8-5.9, and the per capita amount by a factor of 1.1-4.9, across differe

87 Finally, we found that rising per capita gross domestic product (GDPpc) generally led

88 breeding season and used extinction risk and per capita growth rate to measure the strength of the Al

89 or those where individuals have lower income per capita.

90 395 patients, with a median cost of illness per case of $59.99 (IQR, $24.04-$151.23).

91 l perforation, with a median cost of illness per case of US $196.37 (IQR, US $72.89-496.40).

92 re provider, the average direct medical cost per case was US $58.64 (range: US $37.25 at Hospital B,

93 Controls, usually 2 per case, with unrelated conditions who were at the same

94 A data table of aggregate information on a per cell basis, as well as a summary table, is provided

95 eaches a maximum value of ~10(-6) ng of iron per cell.

96 This Faradaic efficiency of over 80 per cent (compared to about 66 per cent for pure Cu) is

97 lene power conversion efficiency of 55 +/- 2 per cent at 150 milliamperes per square centimetre.

98 r ethylene is still low in neutral media (60 per cent at a partial current density of 7 milliamperes

99 cy of over 80 per cent (compared to about 66 per cent for pure Cu) is achieved at a current density o

100 Sixty per cent of LGMDR3 patients carried one of the following

101 Sixty-two per cent of participants had phenotypic features that me

102 nergy peak with an energy resolution of 13.9 per cent.

103 The threshold of CRS/HIPEC number per center per year above which the 90-day POM was signi

104 short-term acute heat stress assays resolved per-colony (genotype) differences that may have been mas

105 ced conidia with fewer septa and more nuclei per compartment than the wild type.

106 o Africa to estimate the risk of importation per country.

107 artile range (IQR) increase [9,200 particles per cubic centimeter (cc)] relative UFP exposure was 1.0

108 magnitude, with a lowest value of 2 x 10(11) per cubic centimeter and most of the deep traps located

109 h a very low average voltage decay of 0.8 mV per cycle as well as a capacity retention of 88.4% withi

110 imum distribution with a mean of 0.5% energy per day (corresponding to TFA intake only from nonindust

111 bjects consuming one more pack of cigarettes per day (P (Interaction) = 1.9 x 10(-7)).

112 eating window to a specified number of hours per day (usually 4-10 h), and fasting (with zero-calorie

113 It is unclear whether the number of steps per day and the intensity of stepping are associated wit

114 epared and applied on the enamel three times per day once a week, for 4 weeks.

115 went a pretreatment biopsy, 6 months of once per day oral talazoparib (1 mg), followed by definitive

116 The mean number of platelet units requested per day was 16.2 (range 0-30); 5.1 (range 0-15) were rec

117 on's disease who had 2 h or more of off time per day with predictable morning off periods, were respo

118 y > 40 mg methylprednisolone [or equivalent] per day).

119 ly) with dietary sodium restriction (60 mmol per day).

120 y assigned (1:1) to either anastrozole (1 mg per day, oral) or matching placebo daily for 5 years.

121 d's population takes at least one medication per day.

122 trend is predicted to accelerate to 3.2-4.4% per decade by 2050.

123 st that the world became ~1.5% more suitable per decade for the development of Ae. aegypti during 195

124 ning lipoprotein(a) levels of at least 60 mg per deciliter (150 nmol per liter).

125 d who had an LDL cholesterol level of 130 mg per deciliter (3.4 mmol per liter) or more and a triglyc

126 ) or more and a triglyceride level of 400 mg per deciliter (4.5 mmol per liter) or less were randomly

127 deciliter in the relugolix group and 58.6 ng per deciliter in the leuprolide group.

128 fter treatment discontinuation were 288.4 ng per deciliter in the relugolix group and 58.6 ng per dec

129 rity of level 2 (blood glucose level, <54 mg per deciliter) or level 3 (severe cognitive impairment)

130 esterol level in the two groups was 255.1 mg per deciliter, despite the receipt of maximum doses of b

131 ty, which quantifies the change in phenology per degree change in temperature.

132 conditions under which the widely used days-per-degree sensitivity approach is subject to methodolog

133 ing a cost-effectiveness threshold of US$500 per disability-adjusted life-year (DALY) averted for our

134 Per each 10-year older age group, the average RNFL thick

135 al muscle activation patterns across muscles per emotion category, or simply distinguishes positive v

136 Averages per encounter by specialty were computed.

137 pent an average of 16 minutes and 14 seconds per encounter using EHRs, with chart review (33%), docum

138 d were asked to perform 1 VF home assessment per eye, per month, for 6 months (12 tests total).

139 gery with 2.2 +/- 1.2 IOP-lowering surgeries per eye.

140 licated genes overall (with prevalence rates per families) were as follows: ABCA4 (20.8%), USH2A (9.1

141 sponses during each of the 5 fractions (5 Gy per fraction), delivered from a clinical linear accelera

142 riole number is maintained at two centrioles per G1 cell.

143 , providing 33.90 +/- 9.06% of injected dose per gram of brain tissue (%ID/g) in the cortex and 17.09

144 .2 and 3.04 +/- 0.3 percentage injected dose per gram, respectively) indicating that (18)F-FAC crosse

145 ke of nuts, seeds, and legumes (beta = -0.05 per gram; 95% CI: -0.09, -0.01).

146 One patient per group (venovenous extracorporeal membrane oxygenatio

147 treated controls (1012 vg per animal, n = 10 per group) with PHP.B vectors.

148 , or NEVKP before autotransplantation (n = 5 per group).

149 at three timepoints (10 males and 10 females per group).

150 /- 4.2 (one standard error) tonnes of carbon per hectare per year from the breakdown of soil organic

151 by more than 50%, from 2.9 to 4.4 megagrams per hectare per year.

152 e and lower-middle-income countries and $237 per HLYG (95% UI 191-303) across upper-middle-income and

153 ns produced cost-effectiveness ratios of $94 per HLYG (95% UI 73-123) across low-income and lower-mid

154 ]), an elevated sedimentation rate of 100 mm per hour (normal range, 0-30 mm per hour), and a C-react

155 ]), an elevated sedimentation rate of 100 mm per hour (normal range, 0-30 mm per hour), and a C-react

156 d adaptation process (1 in 1,000 cells adapt per hour) by simultaneously measuring metabolism and div

157 We used the apnea-hypopnea index (events per hour) to define obstructive sleep apnea severity (no

158 te of 100 mm per hour (normal range, 0-30 mm per hour), and a C-reactive protein level of 203.8 mg/L

159 te of 100 mm per hour (normal range, 0-30 mm per hour), and a C-reactive protein level of 203.8 mg/L

160 Confirmed ORRs per independent radiology review and investigator assess

161 on models adjusting for multiple pregnancies per individual.

162 The odds ratio (OR) per interquartile range (IQR) increase [9,200 particles

163 response rate and progression-free survival per investigator assessment were recorded.

164 In 2019, 128 H. zea neonates per isofamily for a total of 114 F(2) families were scre

165 T with 100% accuracy in less than 10 seconds per isolate.

166 FeCo increased it to 2.7 +/- 0.2 kg CO(2) eq per kg milk because of land use change emissions.

167 from 2.4 +/- 0.1 to 1.6 +/- 0.1 kg CO(2) eq per kg milk, FeCo reduced it to 2.2 +/- 0.1, whereas FoF

168 ic uEV kidney and EV markers (>=4.5 mL urine per lane).

169 is, generating an average of 6.37 insertions per line in a population of 19 independent R1 regenerant

170 +) was found to dramatically reduce the area per lipid in lipid monolayers, while Mg(2+) and Cu(2+) d

171 caused lipid blebbing by decreasing the area per lipid on the side of the bilayer to which the salt w

172 groundwater arsenic exceeding 10 micrograms per liter using a random forest machine-learning model b

173 ride level of 400 mg per deciliter (4.5 mmol per liter) or less were randomly assigned in a 2:1 ratio

174 erol level of 130 mg per deciliter (3.4 mmol per liter) or more and a triglyceride level of 400 mg pe

175 ls of at least 60 mg per deciliter (150 nmol per liter).

176 The high active sites per mass ratio of such hollow HEA nanoparticles makes th

177 termined to be 11.0, 12.1, 13.6, and 15.2 Gy per MBq/mL at image times of 24, 48, 72, and 96 h, respe

178 elements for improving the harvested energy per mechanical cycle, but they are complicated to implem

179 .42]; eosinophil count of at least 150 cells per microliter aOR = 1.54 [95% CI = 1.21-1.97]; and auto

180 itis, eosinophil count of at least 150 cells per microliter, and autoimmune disease were associated w

181 mille (SD), and delta(17)O = -8.77 +/- 0.98 per mille (SD)) using a laser-based off-axis integrated

182 mille (SD), and delta(17)O = -2.37 +/- 0.57 per mille (SD)), and human exhaled breath (EB; deltaD =

183 mille (SD), and delta(17)O = -2.92 +/- 0.79 per mille (SD)), GI fluid (GF; deltaD = -35.91 +/- 7.30

184 per mille (SD), delta(18)O = -3.98 +/- 1.29 per mille (SD), and delta(17)O = -2.37 +/- 0.57 per mill

185 per mille (SD), delta(18)O = -5.41 +/- 1.47 per mille (SD), and delta(17)O = -2.92 +/- 0.79 per mill

186 per mille (SD), delta(18)O = -13.69 +/- 1.23 per mille (SD), and delta(17)O = -8.77 +/- 0.98 per mill

187 xhaled breath (EB; deltaD = -119.63 +/- 7.27 per mille (SD), delta(18)O = -13.69 +/- 1.23 per mille (

188 SD)), GI fluid (GF; deltaD = -35.91 +/- 7.30 per mille (SD), delta(18)O = -3.98 +/- 1.29 per mille (S

189 rinking water (DW; deltaD = -36.59 +/- 10.64 per mille (SD), delta(18)O = -5.41 +/- 1.47 per mille (S

190 lated bulk delta(37)Cl values of 4.1 +/- 4.0 per mille.

191 recurrence (hazard ratio, 0.9 per nanograms per milliliter of PSA; 95% confidence interval [CI], 0.8

192 64-residue proteins (IC(50) ~ 0.16 nanograms per milliliter).

193 t a concentration as low as 0.007 micrograms per milliliter.

194 he chromatograms collected at 1 and 10 parts-per-million (ppm), the enhanced TIC algorithm recovered

195 Compared to India, mean RR was 9.6 breaths per min higher in Guatemala, 12.1 breaths per min higher

196 s per min higher in Rwanda, and 16.1 breaths per min higher in Peru (likelihood ratio test p<0.0001).

197 hs per min higher in Guatemala, 12.1 breaths per min higher in Rwanda, and 16.1 breaths per min highe

198 ed glomerular filtration rate >=25 to <75 mL per min per 1.73 m(2), treated with optimized renin-angi

199 ia was defined as a viral load of 200 copies per mL or more.

200 in care, viral load suppression (<200 copies per mL) was based on the last viral load in the year pre

201 responding to an integer number of electrons per moire unit cell(2-4).

202 peptide conjugates with up to 80 boron atoms per molecule.

203 ked to perform 1 VF home assessment per eye, per month, for 6 months (12 tests total).

204 191) in the randomised cohort and 119 cells per muL (202) in the non-randomised cohort.

205 unts from baseline at week 96 were 205 cells per muL (SD 191) in the randomised cohort and 119 cells

206 or had a viral load of at least 1000 copies per muL after 96 weeks.

207 count for participants who died was 11 cells per muL.

208 47% had a viral load of at least 1000 copies per muL.

209 18-fold changes in the maximum power output per myosin-1C motor and 4-fold changes in the velocity a

210 y related with recurrence (hazard ratio, 0.9 per nanograms per milliliter of PSA; 95% confidence inte

211 se, the range of transcriptional return on a per nuclear basis in myofibers diminishes, which account

212 an 61 for both mean Nursing Activities Score per nurse ratio as well as Nursing Activities Score per

213 sociation between a Nursing Activities Score per nurse ratio greater than 61 for both mean Nursing Ac

214 se ratio as well as Nursing Activities Score per nurse ratio on day 1 and in-hospital mortality remai

215 e detected in workers, fed individually once per os with 10 uL of 25 mM LiCl in sucrose solution (6.5

216 One eye per participant was included.

217 The distribution of TEVAR procedures per pathology varied, with TAA repair constituting from

218 Analysis was performed per patient based on the largest nodule.

219 We showed that multiple histological samples per patient is necessary to effectively capture these pr

220 The mean number of ACP conversations per patient was 1.3.

221 he SI for up to eight brain MRI examinations per patient was measured, and relative SI changes from b

222 The mean costs per patient were US $847 (95% confidence interval [CI] $

223 patients seen, number of services performed per patient, and the amount collected per service.

224 ge net cost of care to the healthcare system per patient, calculated as the difference between reimbu

225 re enrolled with an average 1.7 HBR criteria per patient, including 60.7% >75 years of age, 34.1% on

226 ted with higher health care spending (+$1500 per patient, P < 0.001) compared with patients who did n

227 eal-world population at a cost of under $100 per patient, which makes this combination suitable for e

228 er patient-year; glargine group, 0.46 events per patient-year; estimated rate ratio, 1.09; 95% CI, 0.

229 airment) were low (icodec group, 0.53 events per patient-year; glargine group, 0.46 events per patien

230 and Corticosteroids for Human Septic Shock) per patient.

231 On a per-patient basis, positive predictive value was 93.3% (

232 , which lowered the number of seeds produced per plant.

233 For culture-negative samples, mean cost-per-positive 16S PCR result was pound 568.37 and pound 2

234 8, 2017; 19 021 (94.6%) were included in the per protocol analysis, and 20 071 (99.9%) in the safety

235 Intention-to-treat (ITT) and per-protocol (PP) analyses were undertaken, along with s

236 remaining 151 patients were included in the per-protocol efficacy analyses.

237 as recurrence-free survival, analysed in the per-protocol population.

238 All participants in the per-protocol set developed clade C Env binding antibodie

239 h we find to be on the order of 0.1 electron per proton; experimentally, we also access this quantity

240 In contrast, ICERs were > $175,000 per QALY gained for all strategies for low-risk survivor

241 ncremental cost-effectiveness ratio of $4684 per QALY gained.

242 ingness-to-pay thresholds of $50 000 or more per QALY gained.

243 item Patient Health Questionnaire score >=2) per quarter-year during the 3 years before and the 3 yea

244 Within a detection limit of 42 RNA copies per reaction, SHERLOCK was 100% specific and 100% sensit

245 detection of 6.0 x 10(2) copies of molecules per reaction.

246 Dendritic systems of 20 neurons per region in each brain (N = 640 neurons) were quantifi

247 mple) and high-throughput (up to 384 samples per run) way.

248 tion sites from as little as 500 mug peptide per sample from cells or tissue in a TMT10plex in ca. 5

249 y 1 muL of sample in a fast (less than 1 min per sample) and high-throughput (up to 384 samples per r

250 rix with an effective analysis time of 0.3 s per sample.

251 e of 14% per year, equal to roughly $235,000 per satellite-year in 2040.

252 1.26 [95% CI, 1.18-1.36]; P(PRS)=2.7x10(-11) per SD increase in PRS), independent of family history a

253 <95.3 RU/ml]; HR, 1.26; 95% CI, 1.18 to 1.35 per SD increment in log FGF23).

254 he ubiquitin-proteasome system, mitochondria per se can influence protein homeostasis of cytosolic ag

255 on to the unassembled form, even if assembly per se does not enhance biological function(3-7).

256 pe may be a useful marker beyond performance per se, being heritable and having unique predictive val

257 ubtypes in mice did not induce gastroparesis per se, nor did it protect from PAN-PDE4 inhibitor-induc

258 ch can emit thousands of oral fluid droplets per second.

259 n of a THz-video (32 x 32 pixels at 6 frames-per-second), shown in real-time, using a single-pixel fi

260 formed per patient, and the amount collected per service.

261 Intra-CeA infusions of N/OFQ (1 mug per site) reversed the escalation of oxycodone self-admi

262 ary exosomes, finding on average 5.9 glycans per site.

263 ssociated with increased number of spikelets per spike and decreased kernel size.

264 ylene partial current density of 1.3 amperes per square centimeter at 45% cathodic energy efficiency.

265 ved at a current density of 400 milliamperes per square centimetre (at 1.5 volts versus a reversible

266 a partial current density of 7 milliamperes per square centimetre in the best catalyst reported so f

267 ncy of 55 +/- 2 per cent at 150 milliamperes per square centimetre.

268 the UK Biobank: the estimated hazard ratios per standard deviation were 1.10 (95% confidence interva

269 Four AS-OCT images from one eye per subject were analyzed and parameters describing ACA

270 mart, user-friendly, ultra-low-cost (~0.03 $ per sweat patch), portable, selective, rapid, and non-in

271 e first molecular characterization of the PM-PER tether and show it anchors peroxisomes at the mother

272 The cPRA per titer also risk-stratified candidates for trial incl

273 In conclusion, determining the cPRA per titer is a reliable approach to simplify complex ant

274 extraction costs of approximately US$80-180 per tonne of CO(2).

275 olding trajectories occupied 40% more states per trajectory and occupied those states for longer time

276 d residential properties was real time, ~2 s per tree.

277 s of state anxiety/instability were recorded per trial.

278 easurements support that 0.77 +/- 0.10 parts per trillion by volume (pptv) total inorganic iodine (I(

279 cial spearfishing landings, commercial catch per unit effort (CPUE), and lionfish tournament CPUE als

280 e organs with the highest mean absorbed dose per unit of administered radioactivity were the adrenals

281 ny gain in photosynthetic CO(2) assimilation per unit of leaf area (A) has the potential to increase

282 stest tool for number of sequences processed per unit of time.

283 ows for the prediction of regulatory effects per variant on several cell type-specific chromatin feat

284 The consumption of 1 + servings per week of yogurt at baseline, compared to no yogurt co

285 increase in sales of the original WIC foods per week on average (P < 0.01).

286 increase of log-transformed alcoholic drinks per week were 1.27 ([95% CI, 1.12-1.45] P=2.87x10(-4)) f

287 Patients were treated two to three times per week with high-frequency MST (i.e., 100 Hz) (N = 24)

288 m multiple locations in the school, two days per week, throughout an eight-week sampling period durin

289 , the costs to remove wild pigs averaged $50 per wild pig (6.8 effort hours per wild pig) for removin

290 averaged $50 per wild pig (6.8 effort hours per wild pig) for removing the first 99% of the animals.

291 ortality decreased by 24% (hazard ratio [HR] per year 0.976; 95% confidence interval [CI] 0.959-0.993

292 ional dependence at 3 months after onset (RR per year 0.983; 95% CI 0.968-0.998; p = 0.002 for trend)

293 The threshold of CRS/HIPEC number per center per year above which the 90-day POM was significantly re

294 P of temperate and boreal forests by ~0.2 Gt per year at the end of the century.

295 Because many coral species spawn only once per year during a narrow temporal window, sample process

296 rough early 2010s (images per 1000 enrollees per year for Medicare: -301 [95% CI: -510, -92]; commerc

297 mid to late 2000s (images per 1000 enrollees per year for Medicare: 91 [95% confidence interval {CI}:

298 standard error) tonnes of carbon per hectare per year from the breakdown of soil organic matter.

299 sly documented scale-up reached $559 million per year in 2024; however, costs were offset by long-ter

300 roportion of HIV-1-infected cells within LNs per year on therapy that was similar to that in the part

301 .5 to 2 gigatonnes of carbon dioxide (CO(2)) per year with extraction costs of approximately US$80-18

302 meaning that progression rates (in decibels per year) between eyes likely are correlated.

303 ds (about 860 +/- 160 kilotonnes of nitrogen per year) is limited by a spatial disconnect between hig

304 s an optimal fee that rises at a rate of 14% per year, equal to roughly $235,000 per satellite-year i

305 nd scleritis were 15.39 and 5.54 per 100,000 per year, respectively.

306 n 50%, from 2.9 to 4.4 megagrams per hectare per year.

307 ghly 9 million commercially insured patients per year.

308 claim the lives of around 1.7 million people per year.